News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alpha Szenszor, Inc. and Technion Announce Joint Venture in Lung Cancer Diagnostics


2/5/2013 10:34:36 AM

CARLISLE, Mass. & HAIFA, Israel--(BUSINESS WIRE)--Alpha Szenszor Inc., a leading provider of carbon nanotube based sensors and the Technion -Israel Institute of Technology have announced a joint venture for the commercialization of advanced lung cancer diagnostics based on Volatile Organic Compound (VOC) detection from human breath. The two organizations plan to merge expertise to commercialize an economically viable, non-invasive, digital tool for the early diagnosis of lung cancer. Alpha Szenszor is an e-nose diagnostics company based on carbon nanotube (CNT) sensor chips. The Company has leveraged decades of consumer electronics integration and an extensive IP portfolio to offer direct digital detection of trace gases in low ppb concentrations using low cost, scalable, manufacturing processes.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES